IRIS
FERRARI, GIULIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.894
AS - Asia 2.791
NA - Nord America 2.717
SA - Sud America 750
Continente sconosciuto - Info sul continente non disponibili 145
AF - Africa 64
OC - Oceania 5
Totale 9.366
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.530
RU - Federazione Russa 1.590
CN - Cina 1.040
SG - Singapore 889
BR - Brasile 614
SE - Svezia 426
IT - Italia 388
HK - Hong Kong 319
VN - Vietnam 256
FR - Francia 129
DE - Germania 98
CA - Canada 93
GB - Regno Unito 70
BD - Bangladesh 68
AR - Argentina 56
IN - India 49
FI - Finlandia 33
PL - Polonia 33
JP - Giappone 31
ID - Indonesia 28
MX - Messico 27
AT - Austria 23
EC - Ecuador 21
NL - Olanda 20
IE - Irlanda 19
ZA - Sudafrica 19
ES - Italia 18
TR - Turchia 17
IQ - Iraq 14
VE - Venezuela 14
CR - Costa Rica 13
CL - Cile 11
CO - Colombia 11
HN - Honduras 11
JM - Giamaica 11
PK - Pakistan 11
UA - Ucraina 11
MA - Marocco 9
PE - Perù 9
TN - Tunisia 9
LT - Lituania 8
PY - Paraguay 8
TT - Trinidad e Tobago 8
KE - Kenya 6
KG - Kirghizistan 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
CH - Svizzera 5
GT - Guatemala 5
MY - Malesia 5
PH - Filippine 5
RO - Romania 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
EG - Egitto 4
ET - Etiopia 4
GR - Grecia 4
IL - Israele 4
NP - Nepal 4
BH - Bahrain 3
JO - Giordania 3
KR - Corea 3
NI - Nicaragua 3
PA - Panama 3
QA - Qatar 3
UY - Uruguay 3
AL - Albania 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
LB - Libano 2
PS - Palestinian Territory 2
PT - Portogallo 2
SV - El Salvador 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GP - Guadalupe 1
HT - Haiti 1
IR - Iran 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MD - Moldavia 1
Totale 9.208
Salva come PNG Salva come JPEG
Città #
Ashburn 430
Moscow 387
Singapore 366
San Jose 338
Hong Kong 317
Shanghai 197
Dallas 184
Beijing 160
Council Bluffs 141
Milan 132
Hefei 129
Lawrence 112
Princeton 112
Lauterbourg 111
Ho Chi Minh City 100
New York 71
Los Angeles 58
Phoenix 58
Hanoi 52
Santa Clara 44
São Paulo 41
Boardman 32
Brooklyn 26
Warsaw 26
Helsinki 25
Tokyo 24
Miano 23
Rio de Janeiro 21
Nuremberg 20
Rome 20
Dublin 19
Guangzhou 19
Orem 19
Montreal 16
Poplar 16
Haiphong 15
Belo Horizonte 14
Munich 14
Vienna 14
Cesano Boscone 13
Johannesburg 13
Pune 13
The Dalles 13
Atlanta 12
Da Nang 12
Frankfurt am Main 12
London 12
Toronto 12
Ankara 11
Chennai 11
Houston 11
North Bergen 11
Omaha 11
San Francisco 11
Seattle 11
Brasília 10
Chicago 10
Denver 10
Salvador 10
San José 10
Shenzhen 10
Stockholm 10
Xi'an 10
Dhaka 9
Miami 9
Tianjin 9
Assago 8
Boston 8
Manchester 8
Philadelphia 8
Turin 8
Brescia 7
Campinas 7
Charlotte 7
Hangzhou 7
Kingston 7
Las Vegas 7
Lima 7
Mexico City 7
Mumbai 7
Nova Iguaçu 7
Porto Alegre 7
Quito 7
Thái Bình 7
Washington 7
Wuxi 7
Amsterdam 6
Bishkek 6
Buffalo 6
Caracas 6
Goiânia 6
New Delhi 6
Reston 6
Tashkent 6
Tunis 6
Turku 6
Vilnius 6
Aracaju 5
Caxias do Sul 5
Changsha 5
Totale 4.425
Salva come PNG Salva come JPEG
Nome #
Long-term lineage commitment in haematopoietic stem cell gene therapy 155
Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation 149
Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cells 138
Bone marrow as source of hematopoietic stem cells for human gene therapy of beta thalassemia 136
Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity 124
A clinical protocol for transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA deficient SCID 123
Bone marrow as an alternative site for islet transplantation 120
Transferrin receptor 2 (Tfr2) genetic deletion makes transfusion-independent a murine model of transfusion-dependent β-thalassemia 118
A human PBL immunodeficient mouse model for in vivo preclinical studies of human gene therapy. 118
NCOA4-mediated ferritinophagy in macrophages is crucial to sustain erythropoiesis in mice 118
Correcting b-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity 118
A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease 117
Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease 108
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets 107
Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy 103
Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathway 103
Gene therapy using haematopoietic stem and progenitor cells 103
A Highly conserved SOX6 double binding site mediates SOX6 gene downregulation in erythroid cells 101
Bone marrow as an alternative site for islet transplantation 101
MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27 99
A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers 97
Adenine base editor-mediated correction of the common and severe IVS1-110 (G>A) β-thalassemia mutation 96
Cell-surface marking of CD(34+)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer 95
Correction of ß-thalassemia major by gene transfer in hematopoietic progenitors of pediatric patients 95
The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy 93
An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency 92
Characterization of Papilloma virus polypeptides from bovine cutaneous fibropapillomas 87
Bone marrow-derived stem cells repopulate glomerular and tubular kidney components - Effect of hyperglycemia 86
Unique molecular and functional features of extramedullary hematopoietic stem and progenitor cell reservoirs in humans 85
A non-producer interfering HIV-1 provirus can be transduced through a MLV-based retroviral vector: recovery of an anti-HIV mouse/human pseudotype retrovirus 85
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4 84
Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia 81
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 81
Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy 80
Muscle regeneration by bone marrow-derived myogenic progenitors 79
Stem cell plasticity: time for a reappraisal? 78
Aberrant, noninfectious HIV-1 particles are released by chronically infected human T cells transduced with a retroviral vector expressing an interfering HIV-1 variant 78
Clinical protocol: transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID 78
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 78
Imbalanced TGFβ signalling and autophagy drive erythroid priming of hematopoietic stem cells in β-thalassemia 78
In vivo and in vitro models for the analysis of retroviral vector mediated expression of human ADA in ADA deficient cells from patients affected by severe combined immunodeficiency. 75
Terapia genica e malattia ereditaria 75
Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA- Immunodeficient Patients 74
Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to Plerixafor alone 74
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia 72
Safety of retroviral gene marking with a truncated NGF receptor 71
Protein kinase a-mediated synapsin I phosphorylation is a central modulator of Ca2+-dependent synaptic activity 71
Clonal analysis of stably transduced human epidermal stem cells in culture 71
Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells 70
The second transferrin receptor regulates red blood cell production in mice 70
Myogenic conversion of mammalian fibroblasts induced by differentiating muscle cells 70
Retroviral heterogeneity in mouse lymphomas 70
Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice 70
Hypomorhic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype 69
Down-regulation of SPARC/osteonectin/BM-40 expression in methylcholanthrene-induced fibrosarcomas and in Kirsten-MSV transformed fibroblasts 68
Retroviral vector gene-transfer into donor peripheral-blood lymphocytes for in-vitro selection and in-vivo immunomodulation of donor antitumor immunity after allo-BMT 68
Selective engraftment of genetically modified hematopoietic stem cells by a truncated erythropoietin receptor 68
Pancreatic islets recruit mesenchymal stem cells by release of chemokines 68
Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment 67
Gene-transfer into peripheral-blood lymphocytes for in-vivo immunomodulation of donor antitumor immunity in a patient affected by EBV-induced lymphoma 67
Inhibition of FGF23 is a therapeutic strategy to target hematopoietic stem cell niche defects in β-thalassemia 67
Transfer of the ADA gene into human ADA-deficient T Lymphocytes reconstitutes specific immune functions 66
Gene Therapy Approaches to Hemoglobinopathies 66
Failure to correct murine muscular dystrophy 64
Strain polymorphism and tentative mapping of mouse ornithine decarboxylase 64
Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells 64
Gene therapy for beta thalassemia: preclinical studies on human cells 64
Conditioning Regimens in Long-Term Pre-Clinical Studies to Support Development of Ex Vivo Gene Therapy: Review of Nonproliferative and Proliferative Changes 64
Reversible Immortalization of Human Myogenic Cells by Site-Specific Excision of a Retrovirally Transferred Oncogene 63
Terapia Genica 63
TRANSFER OF THE HSV-TK GENE INTO DONOR PERIPHERAL-BLOOD LYMPHOCYTES FOR IN-VIVO IMMUNOMODULATION OF DONOR ANTITUMOR IMMUNITY AFTER ALLO-BMT 63
Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies 62
Transcription factor binding sites as genetic determinants of retroviral integration in the human genome 62
The homeodomain transcription factor Prep1 (pKnox1) is required for hematopoietic stem and progenitor cell activity 62
Transcript imaging of human T helper cell development using oligonucleotide arrays 61
Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement 61
Towards the correction of the genetic defect in corneal keratinocytes from patients with macular corneal dystrophy type II 61
Retroviral vectors for human gene therapy 61
Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo 60
Transcription Factor Binding Sites Are Genetic Determinant of Retroviral Integration in the Human Genome 60
Mesenchymal Cells Appearing in Pancreatic Tissue Culture Are Bone Marrow-Derived Stem Cells With the Capacity to Improve Transplanted Islet Function 60
In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of beta-thalassemia 60
Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement 59
In vivo and in vitro models for analysis of retroviral vector mediated expression of human ADA in ADA deficient cells from patients affected by severe combined immunodeficiency 59
Safety of retroviral gene marking with a truncated NGF receptor 59
The influence of vector design on integration site selection by gamma-retroviral and lentiviral vectors 59
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermiolysis bullosa 59
gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants 59
Persistent and Position Independent Transgene Expression in Erythroid Cells Transduced 58
Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression into muscle fibers in vivo 58
Sox6 enhances erythroid differentiation in human erythroid progenitors 58
Preclinical Assessment of a Gene Therapy Approach to beta-Thalassemia 58
The GATA1-HS2 Enhancer allows persistent and position-independent expression of ß-globin transgene 57
Deletion of a negatively acting sequence in a chimeric GATA-1 enchancer-LTR greatly increases retroviral-mediated erythroid expression 57
Vector design influences retroviral integration in human hematopoietic cells 57
Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts 57
Muscle-derived hematopoietic stem cells are hematopoietic in origin 57
Phosphorylation of synapsin I by cAMP-dependent protein kinase controls synaptic vesicle dynamics in developing neurons. 56
Gene therapy for beta-thalassemia: Preclinical studies on human cells. 56
In vivo selection of hematopoietic stem cells by a truncated erythropoietin receptor (tEpoR) 56
Totale 7.890
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.964
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022112 0 0 0 43 0 2 1 51 4 5 1 5
2022/2023685 253 169 45 5 2 99 25 52 17 9 6 3
2023/2024369 10 20 30 104 15 45 11 5 0 7 19 103
2024/20251.663 218 42 16 62 48 142 295 177 261 171 105 126
2025/20265.213 409 378 351 804 405 134 424 368 1.411 284 121 124
2026/20271.272 119 355 307 491 0 0 0 0 0 0 0 0
Totale 9.366